117 related articles for article (PubMed ID: 10879101)
1. [Identification of gene aberrations involved in the pathogenesis of multiple myeloma].
Iida S; Ueda R
Rinsho Ketsueki; 2000 May; 41(5):408-13. PubMed ID: 10879101
[No Abstract] [Full Text] [Related]
2. Chromosome changes in human cancer--are they pointers to mechanisms of initiation?
Tawn EJ
Radiat Oncol Investig; 1997; 5(3):97-102. PubMed ID: 9303063
[TBL] [Abstract][Full Text] [Related]
3. Global real-time quantification/reverse transcription-polymerase chain reaction for detecting proto-oncogenes associated with 14q32 chromosomal translocation in multiple myeloma.
Tajima E; Uranishi M; Iida S; Komatsu H; Nitta M; Ueda R
Haematologica; 2005 Apr; 90(4):559-62. PubMed ID: 15820958
[TBL] [Abstract][Full Text] [Related]
4. Etiology of multiple myeloma: what's new.
Berenson JR
Semin Oncol; 1999 Oct; 26(5 Suppl 13):2-9. PubMed ID: 10528889
[TBL] [Abstract][Full Text] [Related]
5. The biology of multiple myeloma.
Drach J; Kaufmann H; Urbauer E; Schreiber S; Ackermann J; Huber H
J Cancer Res Clin Oncol; 2000 Aug; 126(8):441-7. PubMed ID: 10961386
[TBL] [Abstract][Full Text] [Related]
6. Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma.
Rawstron A
Haematologica; 2005 Jul; 90(7):867B. PubMed ID: 15996918
[No Abstract] [Full Text] [Related]
7. [Subclassification of multiple myeloma based on the partner genes of immunoglobulin heavy chain gene translocations].
Nishida K; Taniwaki M
Rinsho Ketsueki; 2000 May; 41(5):414-7. PubMed ID: 10879102
[No Abstract] [Full Text] [Related]
8. Gene expression profiling and multiple myeloma.
Shaughnessy J; Zhan F; Barlogie B; Stewart AK
Best Pract Res Clin Haematol; 2005; 18(4):537-52. PubMed ID: 16026736
[TBL] [Abstract][Full Text] [Related]
9. [Molecular pathogenesis of multiple myeloma].
Iida S
Rinsho Ketsueki; 2006 Mar; 47(3):196-203. PubMed ID: 16629484
[No Abstract] [Full Text] [Related]
10. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in multiple myeloma: it's in the genes.
Bergsagel PL
Clin Cancer Res; 2003 Feb; 9(2):533-4. PubMed ID: 12576415
[No Abstract] [Full Text] [Related]
12. Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination.
Fenton JA; Pratt G; Rothwell DG; Rawstron AC; Morgan GJ
Genes Chromosomes Cancer; 2004 Feb; 39(2):151-5. PubMed ID: 14695995
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 1 abnormalities in multiple myeloma.
Marzin Y; Jamet D; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
Anticancer Res; 2006; 26(2A):953-9. PubMed ID: 16619492
[TBL] [Abstract][Full Text] [Related]
14. Multicolor spectral karyotyping in multiple myeloma.
Sawyer JR
Methods Mol Med; 2005; 113():49-58. PubMed ID: 15968094
[TBL] [Abstract][Full Text] [Related]
15. Duplication of chromosome arms 9q and 11q: evidence for a novel, 14q32 translocation-independent pathogenetic pathway in multiple myeloma.
Liebisch P; Scheck D; Erné SA; Wellmann A; Wendl C; Janczik S; Kolmus S; Kröber A; Einsele H; Straka C; Goldschmidt H; Benner A; Stilgenbauer S; Döhner H
Genes Chromosomes Cancer; 2005 Jan; 42(1):78-81. PubMed ID: 15390182
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and therapeutic significance of myeloma genetics and gene expression profiling.
Stewart AK; Fonseca R
J Clin Oncol; 2005 Sep; 23(26):6339-44. PubMed ID: 16155017
[TBL] [Abstract][Full Text] [Related]
17. Multiple myeloma: why does the disease escape from plateau phase?
Joshua DE; Brown RD; Gibson J
Br J Haematol; 1994 Dec; 88(4):667-71. PubMed ID: 7819092
[No Abstract] [Full Text] [Related]
18. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
[TBL] [Abstract][Full Text] [Related]
19. Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses.
Sáez B; Martín-Subero JI; Largo C; Martín MC; Odero MD; Prosper F; Siebert R; Calasanz MJ; Cigudosa JC
Cancer Genet Cytogenet; 2006 Sep; 169(2):143-9. PubMed ID: 16938572
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetics and molecular cytogenetics in multiple myeloma.
Liebisch P; Döhner H
Eur J Cancer; 2006 Jul; 42(11):1520-9. PubMed ID: 16781866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
